USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$38.09 USD
+0.81 (2.17%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $38.10 +0.01 (0.03%) 7:58 PM ET
4-Sell of 5 4
A Value F Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$38.09 USD
+0.81 (2.17%)
Updated Sep 12, 2024 04:00 PM ET
After-Market: $38.10 +0.01 (0.03%) 7:58 PM ET
4-Sell of 5 4
A Value F Growth A Momentum B VGM
Zacks News
5 DuPont-Tested Winning Stocks
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks.
Pacira (PCRX) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Pacira (PCRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: eXp World, USANA Health Sciences, Fortinet and Logitech International
by Zacks Equity Research
Zacks.com featured highlights include: eXp World, USANA Health Sciences, Fortinet and Logitech International
Power Your Portfolio With These 4 Top-Ranked Liquid Gems
by Zacks Equity Research
Here are four excellent liquid stocks, including Fortinet (FTNT), that can contribute to making an outstanding portfolio for yield-seeking investors.
New Strong Buy Stocks for June 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
New Strong Buy Stocks for June 24th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
DuPont: A Less-Traversed Path to Pick 5 Winning Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
New Strong Buy Stocks For June 17th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
USANA Health Sciences (USNA) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
USANA Health (USNA) delivered earnings and revenue surprises of 115.79% and 20.97%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: USANA Health Sciences, Semler Scientific, EMCOR Group, Vipshop and Renewable Energy Group
by Zacks Equity Research
Zacks.com featured highlights include: USANA Health Sciences, Semler Scientific, EMCOR Group, Vipshop and Renewable Energy Group
Have Faith in DuPont Analysis & Pick These 5 Top Stocks
by Sanghamitra Saha
Do you have more faith in DuPont analysis than simple ROE calculation? If you do, bet on these five stocks.
Earnings Preview: USANA Health Sciences (USNA) Q1 Earnings Expected to Decline
by Zacks Equity Research
USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 DuPont-Tested Winning Stocks
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks.
Zacks.com featured highlights include: USANA Health Sciences, EMCOR, Vipshop and Renewable Energy
by Zacks Equity Research
Zacks.com featured highlights include: USANA Health Sciences, EMCOR, Vipshop and Renewable Energy
Depend on DuPont: Profit From These Top-Ranked Stocks
by Sanghamitra Saha
Why you should depend on the DuPont technique to pick solid profit-generating stocks.
5 DuPont-Tested High Quality Stock Picks as Virus Scare Spreads
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
Jazz Pharma (JAZZ) Surpasses Q4 Earnings & Sales Estimates
by Zacks Equity Research
Jazz Pharmaceuticals (JAZZ) beats fourth-quarter 2019 earnings and revenue estimates. It issues guidance for 2020.
Zacks.com featured highlights include: International Money Express, Tandem Diabetes Care, Kirkland Lake Gold and USANA Health Sciences
by Zacks Equity Research
Zacks.com featured highlights include: International Money Express, Tandem Diabetes Care, Kirkland Lake Gold and USANA Health Sciences
4 Best-Ranked Liquid Stocks for Alluring Returns
by Zacks Equity Research
Four top-ranked liquid stocks that investors can bank on for fat returns.
Zacks.com featured highlights include: AllianceBernstein, Vipshop, Calavo Growers, BMC Stock and USANA Health Sciences
by Zacks Equity Research
Zacks.com featured highlights include: AllianceBernstein, Vipshop, Calavo Growers, BMC Stock and USANA Health Sciences
Buy 5 Top-Ranked DuPont-Tested Stocks Amid Virus Scare
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion
by Zacks Equity Research
Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion
4 Top-Ranked Liquid Bets to Build a Successful Portfolio
by Zacks Equity Research
Here are four excellent liquid stocks that can contribute to making an outstanding portfolio for yield-seeking investors.
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
USANA Health (USNA) delivered earnings and revenue surprises of 43.88% and 6.35%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.